Second generation direct-acting antivirals – Do we expect major improvements?
نویسندگان
چکیده
منابع مشابه
Do we expect enough?
The use of adrenaline in combination with local anesthetics is a broadly extended practice in surgery for extending the anesthetic effect (up to 200%) and achieve improved hemostasia and therefore enhanced visualization in the surgical field.1 In this practice it is important not only to use adrenaline as a vasoconstrictor but also to observe the prescribed time for the said drug to reach its m...
متن کاملWhat Do We Expect from Our Friends?∗
We conduct a field experiment in a large real-world social network to examine how subjects expect to be treated by their friends and by strangers who make allocation decisions in modified dictator games. While recipients’ beliefs accurately account for the extent to which friends will choose more generous allocations than strangers (i.e. directed altruism), recipients are not able to anticipate...
متن کاملMechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
There has been a remarkable transformation in the treatment of chronic hepatitis C in recent years with the development of direct acting antiviral agents targeting virus encoded proteins important for viral replication including NS3/4A, NS5A and NS5B. These agents have shown high sustained viral response (SVR) rates of more than 90% in phase 2 and phase 3 clinical trials; however, this is sligh...
متن کاملWhat are we and what do we expect to become?
EDITORIAL What are we and what do we expect to become? ଝ ¿Qué somos y qué queremos ser? A major medical association needs a powerful, exciting, balanced, training medical journal, which is attractive to authors and readers, and which is also sustainable, so that it can endure. ActasUrológicasEspañolas, official journal of the Spanish Association of Urology and the American Urological Confederat...
متن کاملHepatocellular carcinoma and direct-acting antivirals: A never ending story?
A large body of evidence accumulated over the two decades of the “interferon era” shows conclusively that HCV eradication (sustained virological response, SVR) in patients with cirrhosis reduces both liver and nonliverrelated deaths.1,2 When cirrhosis is subclassified ac‐ cording to the stage of portal hypertension, it is apparent that the benefit of SVR is higher in patients without clinically...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Hepatology
سال: 2016
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2016.07.007